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Abstract 
Human autologous bioengineered skin has been successfully developed and used to treat skin injuries in a growing number of 
cases. In current clinical studies, the biomaterial used is fabricated via plastic compression of collagen hydrogel to increase 
the density and stability of the tissue. To further facilitate clinical adoption of bioengineered skin, the fabrication technique 
needs to be improved in terms of standardization and automation. Here, we present a one-step mixing technique using highly 
concentrated collagen and human fibroblasts to simplify fabrication of stable dermal equivalents. As controls, we prepared 
cellularized dermal equivalents with three varying collagen compositions. We found that the dermal equivalents produced 
using the simplified mixing technique were stable and pliable, showed viable fibroblast distribution throughout the tissue, and 
were comparable to highly concentrated manually produced collagen gels. Because no subsequent plastic compression of 
collagen is required in the simplified mixing technique, the fabrication steps and production time for dermal equivalents are 
consistently reduced. The present study provides a basis for further investigations to optimize the technique, which has 
significant promise in enabling efficient clinical production of bioengineered skin in the future. 
Keywords: Skin, Automation, Tissue Engineering, Bovine Collagen, Plastic Compression 
 
1. Introduction 
Autologous tissue-engineered skin grafting is a promising 
approach for the treatment of skin injuries, such as burns or 
scars [1,2]. Such skin grafts facilitate wound healing and 
restore skin function while overcoming donor site limitations 
and immune rejection [3,4], and have been successfully used 
in initial clinical studies [5]. However, the fabrication of 
dermal equivalents is complex and time consuming using 
current fabrication techniques, and simplification could result 
in higher standardization and lower costs, which is a valuable 
aspect for commercial translation. 
Regarding the process of skin tissue engineering, biopsied 
skin cells are isolated and rapidly expanded in vitro. 
Combined with a scaffold biomaterial, the cells are formed 
into biomimetic tissue and transplanted back onto the patient 
[6]. 
Over the last few decades, various scaffold biomaterials 
have been established for creating dermal equivalents of 
bioengineered skin [3,7–9], and are currently being applied 
in clinical practice [10–15]. In the present study, we focused 
on the use of natural biomaterials, namely collagen, due to 
successful outcomes in clinical settings [5,11]. In skin 
substitutes, the scaffolds mimic the extracellular matrix 
(ECM) and provide mechanical stability to the graft, which is 
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essential for convenient surgical handling. However, several 
products lack handling properties suitable for a practical 
clinical application [16], and are based on complex and 
intricate fabrication techniques that reduce repeatability and 
standardization. To overcome these limitations, Brown et al. 
[17] have reported a method that increases the stability of 
collagen scaffolds. To achieve high mechanical stability, 
collagen hydrogel is compacted using external pressure by 
displacing water and increasing the final collagen density. 
Braziulis et al. [16] have improved this technique and used 
dermal scaffolds in clinical applications [5]. 
Furthermore, automated biofabrication is crucial in 
improving standardization and production robustness, as well 
as cost-effectiveness. In addition, a simplification of the 
fabrication process reduces complexity in the automation 
setup. One promising approach toward automated 
biofabrication is 3D bioprinting [18], particularly bioprinting 
of the skin, which has been successfully used in vitro and in 
animal models. A review of this approach was recently 
published [8]. Several different biomaterials are currently 
being developed for 3D bioprinting [19,20]. However, 
natural biomaterials, such as collagen, are typically used at 
an extremely low concentration [21,22]. As a result, 
additional treatment, such as chemical crosslinking, is 
required, or a mechanically fragile tissue is obtained. 
In the present study, we aimed to combine the best of both 
worlds; using an established natural biomaterial to result in 
high mechanical stability and simplifying fabrication. 
We developed a fabrication technique inspired by 
extrusion mixing, in which collagen and fibroblasts were 
continuously extruded through a 3D printed mixing chamber 
into a culture well to form in vitro dermal equivalents. This 
technique for creating cellularized dermal equivalents 
requires only one fabrication step and is capable of 
processing highly concentrated collagen solutions that allow 
compression to be avoided. As controls, three collagen 
compositions were prepared manually; 5 mg/mL non-
pepsinized collagen I, a standard used for in vitro skin 
models [23], 25 mg/mL non-pepsinized collagen, and 
25 mg/mL pepsinized collagen. The dermal equivalents 
fabricated using the simplified mixing technique were 
investigated to evaluate cell viability and compared to the 
control gels in terms of stability/pliability, cell distribution, 
and cell morphology. We found that the resulting dermal 
equivalents showed good cell viability, cell morphology, and 
spatial distribution, and had fine handling properties. Our 
results indicate that the use of this biomaterial and 
fabrication process is feasible for the simplification of the 
production of clinically applicable skin grafts. 
2. Materials and Methods 
2.1. Cell Culture 
Human foreskin samples were harvested from patients 
aged between 6 and 16 years old. Approval was obtained 
from the Ethics Committee of the Canton Zurich, 
Switzerland. Parents or patients gave informed consent to use 
the skin samples. Skin biopsies were used for the isolation of 
dermal fibroblasts as described previously [16]. Skin samples 
were minced into small pieces (10 mm2) and digested for 15–
18 hours at 4°C in 12 U/mL dispase in Hank’s balanced salt 
solution containing 5 mg/mL gentamycin. The epidermis and 
dermis were mechanically separated using forceps. The 
dermal tissue was digested in 2 mg/mL collagenase 
(Clostridiopeptidase A) for 60 minutes at 37°C. Isolated cells 
were seeded on cell culture dishes containing fibroblast 
growth medium (Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal calf serum [FCS], 4 
mM L-alanyl-L-glutamine, 1 mM sodium pyruvate, and 5 
mg/mL gentamycin) and allowed to attach overnight (37°C, 
5% CO2). Fibroblasts were further cultured until Passage 5 in 
the medium mentioned above at 37°C and 5% CO2. The 
transfection of human fibroblasts with a green fluorescent 
protein (GFP)-expressing cDNA sequence was performed as 
described previously [24]. 
2.2. Manual preparation of dermal equivalents 
Three different collagen compositions were manually 
mixed with human-derived skin fibroblasts to form a dermal 
equivalent. Non-pepsinized bovine collagen Type I at 
concentrations of 5 mg/mL and 25 mg/mL, as well as 
pepsinized bovine collagen Type I at a concentration of 
25mg/mL in 0.063M acetic acid were used. A preparation of 
5 mg/mL non-pepsinized bovine collagen Type I served as 
control [16]. The acidic solutions of bovine collagen Type I 
were neutralized on ice via addition of 0.5 M NaOH. 
Multiple dermal equivalents of each composition were 
formed manually with a spatula in Corning Transwell six-
well inserts with a diameter of 24 mm (Figure 1A, n = 6). 
The green fluorescent protein (GFP)-expressing human 
dermal fibroblasts were seeded at 3 × 106 cells per hydrogel, 
with a mixing time of approximately 30 seconds each. 
Fibroblast growth medium was added after the hydrogel 
cured and the preparation was cultured for seven days at 
37°C in a humidified atmosphere containing 5% CO2. The 
medium was renewed every 2–3 days. The collagen was 
acquired from Symatese (Chaponost, France). All other 
compounds were obtained from Invitrogen (Basel, 
Switzerland). 
2.3. Simplified technique for high-collagen dermal 
equivalents 
For the fabrication of a dermal equivalent using the 
molding technique, a simple extrusion module composed of 
two plastic syringes (3 mL and 5 mL) and a disposable 3D-
printed mixing chamber was designed (Figures 1B–D). The 
mixing chamber was designed using the Siemens NX10 
Software (Siemens PLM Inc., USA) and printed on a Form 2 
SLA Printer (Formlabs Inc., USA) with clear resin 
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(GPCL02) and then sterilized using 70% ethanol. Figure 1 D 
illustrates the fluid path. The cell medium is guided into a 
barrel-shaped cavity with openings toward the front. To 
reduce stress on the cells, the viscous collagen is guided 
above and below the barrel shape, and the cells exiting the 
barrel openings are “sandwiched” in between the top and 
bottom collagen streams (as illustrated in the side view). 
Furthermore, as visible in the top view, the mixture is guided 
through a tunnel with distributed mixing columns. The 
complete molding module was intended for single use. 
An acidic solution of highly concentrated (25 mg/mL) 
non-pepsinized bovine collagen Type I was prepared in a 
sterile 5 mL syringe and kept on ice until use. A total of 3 x 
106 (GFP)-expressing human dermal fibroblasts were 
suspended in DMEM in a second sterile 3 mL syringe and 
shortly before mixing, a buffer containing 200 mM HEPES, 
0.32 M NaHCO3, and 0.15 M NaOH was added as described 
previously [16]. The loaded syringes were connected to the 
3D-printed mixing chamber and sealed with O-rings. The 
content was injected through the mixing chamber and 
distributed into multiple Transwell® six-well inserts. The 
first 1 mL aliquot of the mixture was discarded to ensure 
homogeneity. A plastic ring in the insert helped distribute the 
gel (not shown). The extrusion time per gel was less than 15 
seconds. The dermal equivalents were left at room 
temperature for 15 minutes to allow the hydrogels to cure 
before the fibroblast growth medium was added. Culturing 
was done for seven days at 37°C in a humidified atmosphere 
containing 5% CO2.  
Homogenous mixing with the nozzle was initially 
assessed via visual observation of colored water (blue and 
red coloring; Dr. Oetker, Bielefeld, Germany) Additionally, 
to account for high viscosity of the biomaterial, mixing was 
assessed visually with the described collagen and buffer, 
both stained with phenol red (Sigma Aldrich, St. Louis, MI, 
USA). For Figures 3 C and D, color saturation of the pictures 
was increased with Apple Preview (Apple, Cupertino, CA). 
2.4. Analysis of spatial distribution of cells and cell 
viability 
Each hydrogel was analyzed at three different depths with 
fluorescence microscopy. The morphology and spatial 
distribution of the cells were observed. This optical study 
occurred for seven days and in three layers. The layers are 
shown in Figure 2. The dermis equivalents were initially 
examined under the microscope and at 2, 6, 24 and 48 hours 
(not shown), as well as at day seven after the mixing process. 
Fluorescence microscopy pictures were acquired using a 
DXM1200F digital camera connected to a Nikon Eclipse 
TE2000-U inverted microscope equipped with an FITC filter 
or a Nikon SMZ1500 stereo microscope with FITC filters 
(Nikon AG, Egg, Switzerland; Software: Nikon ACT-1 
version 2.70). The depth positions were initially set via the 
focus, marked, and then repositioned. Microscopic and 
macroscopic images were post-processed using Photoshop 
10.0 (Adobe Systems Inc., Munich, Germany) for cropping 
and contrast, color, and background enhancements. 
For cell viability assay following the simplified mixing 
technique, dermal equivalents were fabricated as described 
above in a volume of 50 µL with 10,000 primary human 
dermal fibroblasts each and extruded into a commercially 
available 96-well plate. The gels were suspended in 
fibroblast growth medium, incubated for 1.5 h, and 
collagenase (4 mg/mL) was then added. The gels were 
incubated for an additional 1.5 h until the gel was digested. 
Cell viability was measured 3 h after fabrication using a 
trypan blue exclusion assay and an automated cell counter 
(Countess II, Invitrogen). In addition, cell viability was 
observed after 24 h via resazurin reduction assay (CellTiter-
Blue®, Promega, Madison, Wisconsin, USA; similar to 
alamarBlue™). A total gel volume of 50 µL with 5,000 
fibroblasts were either extruded using the simplified mixing 
technique or manually mixed (as positive control), as 
described above, into a 96-wells plate and suspended in 
fibroblast growth medium. Non-cellularized gels were added 
as negative controls. After 24 h of incubation, 10 µL of 
CellTiter Blue® dye was added and incubated for another 4 
h. Fluorescence measurements were obtained with a plate 
reader (BioTec Synergy HT, Winooski, Vermont, USA) at 
530/590 nm. Because CellTiter Blue® is nontoxic, the assay 
was conducted on the same samples again 72 h after 
fabrication for an indication on cell proliferation. 
2.5. Statistical analysis 
The microscopy images were analyzed automatically with 
MATLAB (MathWorks Inc., Natick, USA). The images 
were binarized (translated into black and white) with a 
sensitivity parameter of 0.8 using the function IM2BW [25]. 
The images were further scanned with circle detection 
(function: imfindcircles [26]) with an edge threshold 
parameter of 0.15. This function counted the number of cells 
in each image. An average of six images was taken at upper, 
middle, and bottom depths respectively and approximately 
650 cells were counted. The numbers were then manually 
transferred to Excel (Microsoft, Redmond, USA). 
2.6. Analysis of pliability 
For convenient handling, a prerequisite of dermal 
equivalents is their mechanical stability. After seven days of 
cultivation, the dermal equivalents were taken out of the 
Transwell inserts and mechanically manipulated with 
forceps. Their robustness was evaluated with a focus on 
folding and ripping when taken out of the insert, and 
compared to previously reported results [16]. 
3.Results 
In the present study, we used a highly concentrated 
collagen biomaterial and a simplified mixing technique 
(Figures. 1 B–D) to produce stable cellularized dermal 
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equivalents (Figure. 2 A) and compared them to dermal 
equivalents produced manually using different collagen 
compositions (Figures. 2 B–D). 
The mixing nozzle achieved a homogenous mixture of the 
colored water, and the color of the phenol red-stained 
components showed neutralization of the mixture toward the 
nozzle tip (Figures. 3 A–D). 
The fabrication of dermal equivalents with the simplified 
mixing technique proved to be very fast and allowed the 
production of three ø24 mm gels in succession in only 15 
seconds each. The fabricated gels formed well in the insert 
and showed homogenous opaqueness, except for a slight 
increase in collagen density in the center where the nozzle 
was placed. The hydrogels reached the walls of the Transwell 
insert, thereby obtaining a uniform shape (circle) and size 
(ø24 mm). The stability of the hydrogels was particularly 
high; no folding or ripping occurred when they were handled 
with the forceps (Figure. 2 A). Our designed and 3D-printed 
mixing nozzle provided sufficiently homogenous mixing 
(Figures. 3 A, B). 
To investigate the biological characteristics of the 
prepared gels, the viability of the processed fibroblasts was 
measured 3 h after fabrication and was found to be 91.7% ± 
5.1% (n=30). Fluorescent cell viability analysis after 24 h 
showed a slightly higher viability (mean: 6% high, p = 0.002, 
two-tailed t-test, n = 30) for the fibroblasts with the 
simplified mixture than in the manually fabricated control. 
Similar results after 72 h (mean 7%, p=0.003) further 
indicate positive cell proliferation. Microscopic cell 
morphology analysis showed normal elongated fibroblasts 
with similar morphology as in the 5 mg/mL control gels over 
seven days of culture in the upper, middle, and bottom layers 
(Figures. 2 A‘–A‘‘ and Figures. 2 B‘–B‘‘ respectively). 
When comparing the distribution of the cells throughout the 
gel, no significant difference was found between simplified 
mixing and manual preparation in the number of cells in the 
three different layers initially after preparation (both 25 
mg/mL non-pepsinized collagen, p > 0.05, two-tailed t-test, 
shown in Figure. 3C). 
The control gels prepared manually with the standard 
composition of 5 mg/mL showed a transparent hydrogel with 
a consistent reddish color with fibroblasts found throughout 
all layers of the gel (Figures. 2B–B‘‘‘, after seven days in 
culture). However, these dermal equivalents were very 
fragile when handled manually. The hydrogels folded and 
ripped easily when manipulated with forceps and their 
removal from the six-well insert was delicate, with a high 
probability of being destroyed. 
The gels formed manually with the increased collagen 
concentration of 25 mg/mL non-pepsinized collagen (as in 
the mixing technique) formed an opaque gel with high 
mechanical stability; however, the collagen gelled very 
quickly and clumping occurred in the mixing process, which 
formed bulges on the surface. The fibroblasts were found in 
all layers of the gel (Figures. 2 C–C‘‘‘). 
The pepsinized collagen composition of 25 mg/mL 
showed the lowest homogeneity and stability, with both 
transparent as well as opaque areas (Figures. 2D), and most 
gels ruptured when manipulated with forceps. We further 
observed an inhomogeneous distribution, with most of the 
fibroblasts at the bottom of the gel on the insert membrane. 
4.Discussion 
In the present study, we hypothesized that it is feasible to 
accelerate the fabrication of stable dermal equivalents with 
the use of highly concentrated collagen and a simplified 
mixing technique. We developed a mixing technique that 
allowed for the fabrication of dermal equivalents in under 15 
seconds, which is considerably faster than the current 
approach of plastic compression [16,17]. 
The dermal equivalents (Figure. 2A) were compared to 
dermal substitutes prepared using an established manual 
fabrication technique (Figures. 2B–C). The equivalents were 
analyzed in terms of viability, spatial distribution, and 
handling properties. 
The simplified mixing technique created robust and 
pliable dermal equivalents, with viable cells homogenously 
distributed throughout the hydrogel. After the mixing process 
in vitro, the fibroblasts showed a typical phenotype 
throughout seven days of culture. Pliability and handling 
were comparable with the high concentrated dermal 
equivalent controls and with earlier results fabricated with 
plastic compression [16]. Both morphology and spatial 
distribution of the fibroblasts were comparable with those in 
traditionally prepared dermal equivalents (Figure. 2B). 
Viability after our mixing process was high, with 91.7% 
viable cells compared with 82.3% in a previous study that 
used plastic compression [17]. This is a positive indication; 
however, a reliable viability must be compared in a specific 
comparative study with identical cells and viability assays. 
After 24 h and 72 h, the viability and proliferation showed 
comparable results for the manually prepared gels and the 
cells processed using the mixing nozzle. This is another 
positive indication for simplified mixing feasibility. 
However, several factors might influence this test, such as 
the diffusion of the dye into the gel and the air introduced via 
manual mixing. 
The use of the 3D printed mixing nozzle allowed us to 
quickly implement our idea and provided sufficient mixing 
and cell viability. In addition, commercially available mixing 
nozzles will be considered for future use because they are 
readily available, can be acquired pre-sterilized, and provide 
a cost-effective alternative (e.g medmix L-System, Medmix, 
Rotkreuz, Switzerland) However, cell viability, mixing, and 
implementation using these nozzles needs to be investigated. 
The use of 25 mg/mL non-pepsinized biomaterial in 
combination with the mixing technique we developed 
represents potential improvement in the commercial 
fabrication of cellularized dermal equivalents, because it 
reduces the process to a single step allowing for simpler and 
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more efficient scale-up, which is important for the 
production of large numbers of tissues and commercial 
exploitation [27]. Recently, the importance of scalability has 
been observed in the area of electrospinning [28]. For clinical 
applications, the biomaterial could be pre-prepared in the 
syringe with the mixing nozzle and stored until needed. 
The biomaterial and mixing technique described here 
could also be beneficially implemented in combination with 
automation techniques like 3D bioprinting or injection 
molding. In the extrusion printing of high-collagen dense 
constructs, cells need to be mixed thoroughly (e.g., 40 
aspiration cycles) with the scaffold material used in advance 
to create the bioink [29,30]. In our mixing technique, the 
biomaterial is only mixed gently with the cells at the moment 
of extrusion. 
Gel contraction, known to occur in fibroblast-containing 
collagen gels [31], was not monitored. Slight contraction was 
observed toward the end of the seven-day culture period in 
some of the 5 mg/mL dermal equivalents, but not in the 25 
mg/mL non-pepsinized gels. Further investigation of the 
influence of our protocol on gel contraction needs to be 
conducted. 
In general, the experimental setup of the one-step mixing 
technique allowed us to test fundamental principles. Some 
aspects still need to be improved for high-quantity 
production using the mixing technique. The production 
should be further actuated by a motor, e.g. a syringe pump, to 
investigate and define crucial parameters for standardization 
of the automated process. In relation to this, a detailed study 
on the optimal mixing nozzle design, mechanical stability 
testing, and viability and cell proliferation must be performed 
in the future. 
It should also be noted that we solely focused on the 
production of the dermal equivalent. An automated 
application using keratinocytes to create the epidermis and to 
fabricate a bioengineered dermo-epidermal skin substitute is 
still required. 
Future improvements in the mixing technique are intended 
to enable fully automated production of dermo-epidermal 
skin substitutes, which can then be compared to current state-
of-the-art products. Our mixing technique has remarkable 
innovative potential because of its simplicity, ease-of-use, 
distinctive robustness, and cost-effectiveness in automation 
and standardization of the fabrication of bioengineered skin 
substitutes. 
5.Conclusion 
In the present study, we introduce a biomaterial in 
combination with a simplified automatable one-step mixing 
technique to fabricate dermal equivalents with high structural 
stability within seconds. We show that one-step mixing of 
highly concentrated collagen with dermal fibroblasts is 
feasible, with promising results in terms of cell viability, 
spatial distribution, and handling properties. The mixing 
technique is faster than the traditional dermal equivalent 
production and is amenable for efficient automation. 
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Figures: 
  
 
Figure 1. Two different production techniques are illustrated. (A) Manual production: manual spatula mixing of 
green fluorescent protein (GFP)-expressing fibroblasts suspended in buffer and collagen. (B, C) Mixing 
technique: a simple extrusion module composed of two plastic syringes of different sizes, and a disposable 3D-
printed mixing chamber was developed. GFP-expressing fibroblasts suspended in buffer and collagen were 
loaded in separate syringes, both connected to a 3D-printed mixing chamber. The contents were injected via the 
mixing chamber, mixed, and distributed into multiple 24-mm Transwell six-well filter inserts. (D) The 3D-
printed mixing chamber is illustrated with the Siemens NX 10/Adobe Illustrator software. Illustrative fluids 
were used for better image visibility. 
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Figure 2. Investigation of the influence of high collagen concentration and the simplified mixing technique on 
hydrogel stability and biological characteristics. (A–A‘‘‘) Dermal equivalents prepared using the mixing 
technique. (A) Macroscopic view of a highly concentrated non-pepsinized bovine collagen type I (25 mg/mL) 
hydrogel showing quality and fine handling properties. (A‘–A‘‘‘) Fluorescence microscopy of green fluorescent 
protein (GFP)-expressing fibroblasts showing typical fibroblast morphology and distribution in the upper, 
middle, and bottom areas of the highly concentrated non-pepsinized hydrogel. (B–B‘‘‘) Manually prepared 
dermal equivalents. (B) Macroscopic view of a non-pepsinized low-concentration bovine collagen type I (5 
mg/mL) control hydrogel showing quality and poor handling properties. (B‘–B‘‘‘) Fluorescence microscopy of 
GFP-expressing fibroblasts showing typical fibroblast morphology and distribution in the upper, middle, and 
bottom areas of the non-pepsinized low-concentration hydrogel. (C–C‘‘‘) Manually prepared dermal 
equivalents. (C) Macroscopic view of a non-pepsinized high-concentration bovine collagen type I (25 mg/mL) 
control hydrogel showing quality and good handling properties. (C‘–C‘‘‘) Fluorescence microscopy of GFP-
expressing fibroblasts showing typical fibroblast morphology and distribution in the upper, middle, and bottom 
areas of the non-pepsinized high-concentration hydrogel. (D–D‘‘‘) Manually prepared dermal equivalents. (D) 
Macroscopic view of a pepsinized high-concentration bovine collagen type I (25 mg/mL) control hydrogel 
showing quality and poor handling properties. (D‘–D‘‘‘) Fluorescence microscopy of GFP-expressing 
fibroblasts showing fibroblast morphology and non-equal distribution in the upper and middle areas with high 
distribution in the bottom area of the pepsinized high-concentration hydrogel. All images were obtained on day 
7. Scale bar: A–D, 1 cm; all other pictures, 200 µm. 
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Figure 3. Colored mixing assessment and statistical analysis. (A, B) Side and top views of the mixing nozzle 
while mixing colored water. The individual syringes were filled with red or blue colored water for better 
visibility, and the exiting droplets showed a uniform violet color. (C, D) In addition, to account for the high 
collagen viscosity, both the described high concentrated collagen (25mg/mL) and buffer solution were colored 
with phenol red. The mixture shows progress from yellow to rose color toward the tip, which is an indication 
of the ongoing pH neutralization. (E) To assess the cell distribution in the vertical direction, the microscopy 
images of the high-concentration collagen dermal equivalents were analyzed. The cells were counted in the 
microscopy capture frame at three levels in the hydrogels using the developed mixing technique or manual 
preparation. The bars show the number of visible cells in the corresponding layers and the standard deviation 
illustrating the comparability of the techniques. 
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